LSE:BEZ 22 January 2026 - 13 June 2026

Johnson & Johnson finished Friday at $240.87, up 1.07%. The stock outperformed other big healthcare names as the S&P 500 added 0.50% and the Dow Jones Industrial Average climbed 0.70%. The Dow, being price-weighted, gives more influence to higher-priced stocks like J&J. S&P Dow Jones Indices calls the Dow a gauge of 30 U.S. blue-chip companies.

Monday’s wave of UK takeover disclosures pulled the curtain back on Beazley Plc’s share register as Zurich Insurance’s £8.1 billion offer rolls forward. Wellington Management reported a 6.21% stake, Vanguard showed 5.03%, and Polar Capital registered 1.33%. Hedge funds, too, surfaced with their holdings.

Beazley shares edged up 0.4% to 1,225 pence as of 0819 GMT, after the UK Takeover Panel pushed Zurich Insurance Group’s “put up or shut up” deadline to 5 p.m. London time on March 4. Zurich’s bid for the Lloyd’s market specialist remains unconfirmed, leaving investors weighing their next move.

Beazley shares held steady around 1,240 pence in early London trade Thursday, following a strong jump the previous day triggered by Zurich Insurance Group’s enhanced takeover offer. The stock has remained confined to a tight range today. Beazley is set to release its next earnings report on March 4.

Beazley shares slipped slightly in early London trade Tuesday, as investors continue to view the stock through the lens of a potential takeover rather than just an insurance play. At 0802 GMT, the shares were down 0.1%, trading at 1,138.5 pence.